499 related articles for article (PubMed ID: 32883070)
41. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
Braga CB; Perli G; Becher TB; Ornelas C
Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
[TBL] [Abstract][Full Text] [Related]
42. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies.
Wang L; Liu Z; He S; He S; Wang Y
J Mater Chem B; 2021 Jun; 9(22):4587-4595. PubMed ID: 34059856
[TBL] [Abstract][Full Text] [Related]
43. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
44. Engineering Supramolecular Nanomedicine for Targeted Near Infrared-triggered Mitochondrial Dysfunction to Potentiate Cisplatin for Efficient Chemophototherapy.
Zhang W; Du XF; Liu B; Li C; Long J; Zhao MX; Yao Z; Liang XJ; Lai Y
ACS Nano; 2022 Jan; 16(1):1421-1435. PubMed ID: 34962119
[TBL] [Abstract][Full Text] [Related]
45. Multifunctional Carbon Monoxide Prodrug-Loaded Nanoplatforms for Effective Photoacoustic Imaging-Guided Photothermal/Gas Synergistic Therapy.
Lin Y; Zhong W; Wang M; Chen Z; Lu C; Yang H
ACS Appl Bio Mater; 2021 May; 4(5):4557-4564. PubMed ID: 35006792
[TBL] [Abstract][Full Text] [Related]
46. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
Chen F; Qin X; Xu G; Gou S; Jin X
Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
[TBL] [Abstract][Full Text] [Related]
47. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
Chen H; Wang X; Gou S
J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
[TBL] [Abstract][Full Text] [Related]
48. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
[TBL] [Abstract][Full Text] [Related]
49. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
Li L; Huang X; Huang R; Gou S; Wang Z; Wang H
Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of nanoparticle delivered cisplatin in beagles.
Feldhaeusser B; Platt SR; Marrache S; Kolishetti N; Pathak RK; Montgomery DJ; Reno LR; Howerth E; Dhar S
Nanoscale; 2015 Sep; 7(33):13822-30. PubMed ID: 26234400
[TBL] [Abstract][Full Text] [Related]
51. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle.
Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547
[TBL] [Abstract][Full Text] [Related]
52. Self-Distinguishing and Stimulus-Responsive Carrier-Free Theranostic Nanoagents for Imaging-Guided Chemo-Photothermal Therapy in Small-Cell Lung Cancer.
Zhu Q; Fan Z; Zuo W; Chen Y; Hou Z; Zhu X
ACS Appl Mater Interfaces; 2020 Nov; 12(46):51314-51328. PubMed ID: 33156622
[TBL] [Abstract][Full Text] [Related]
53. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
54. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
[TBL] [Abstract][Full Text] [Related]
55. Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.
Ling X; Chen X; Riddell IA; Tao W; Wang J; Hollett G; Lippard SJ; Farokhzad OC; Shi J; Wu J
Nano Lett; 2018 Jul; 18(7):4618-4625. PubMed ID: 29902013
[TBL] [Abstract][Full Text] [Related]
56. Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin.
Fang T; Ye Z; Wu J; Wang H
Chem Commun (Camb); 2018 Aug; 54(66):9167-9170. PubMed ID: 30062328
[TBL] [Abstract][Full Text] [Related]
57. Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.
Yang J; Su H; Sun W; Cai J; Liu S; Chai Y; Zhang C
Theranostics; 2018; 8(7):1966-1984. PubMed ID: 29556368
[TBL] [Abstract][Full Text] [Related]
58. Dual drug-paired polyprodrug nanotheranostics reverse multidrug resistant cancers via mild photothermal-cocktail chemotherapy.
Du C; Ding Y; Qian J; Zhang R; Dong CM
J Mater Chem B; 2019 Sep; 7(35):5306-5319. PubMed ID: 31411235
[TBL] [Abstract][Full Text] [Related]
59. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
[TBL] [Abstract][Full Text] [Related]
60. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.
Ling X; Tu J; Wang J; Shajii A; Kong N; Feng C; Zhang Y; Yu M; Xie T; Bharwani Z; Aljaeid BM; Shi B; Tao W; Farokhzad OC
ACS Nano; 2019 Jan; 13(1):357-370. PubMed ID: 30485068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
